biote Corp.

biote Corp. (Nasdaq: BTMD), formerly the de-SPAC target of Haymaker Acquisition Corp. II (ticker: HYAC), filed an 8-K with the SEC on June 9, 2023. Haymaker Acquisition Corp. II, sponsored by Haymaker Sponsors II LLC, completed its initial public offering in 2021 as a blank-check company targeting the healthcare sector. The SPAC merged with biote Corp., a hormone optimization and bioidentical hormone replacement therapy company, with the combined entity subsequently trading under the ticker BTMD on Nasdaq. The June 2023 8-K represents a routine post-combination current report filed under the former SPAC's SEC registration. Sign up at SpacDesk for full filing history, deal analytics, and real-time data on this and every active SPAC.